Hans Prenen professor

Publications Hans Prenen

Highlights in gastro-intestinal cancer

Source
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Author(s)

Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer : results from the phase 1a/1b EMBER study

Source
Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 172-181
Author(s)
    Kan Yonemori, Valentina Boni, Kim Gun Min, Tarek M. Meniawy, Janine Lombard, Peter A. Kaufma, Debra L. Richardson, Laura Bender, Meena Okera, Koji Matsumoto, Karthik V. Giridhar, Jose Angel Garcia-Saenz, Hans Prenen, Bernard Doger Speville de Uribe, Don S. Dizon, Javier Garcia-Corbacho, Els Van Nieuwenhuysen, Yujia Li, Shawn T. Estrem, Bastien Nguyen, Francesca Bacchion, Roohi Ismail-Khan, Komal Jhaveri, Kalyan Banda

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma

Source
EBioMedicine - ISSN 2352-3964-109 (2024) p. 1-12
Author(s)
    Loic Verlingue, Antoine Italiano, Hans Prenen, Eva Maria Guerra Alia, Diego Tosi, Ruth Perets, Iwona Lugowska, Vladimir Moiseyenko, Mahmut Gumus, Cagatay Arslan, Colin R. Lindsay, Sanjeev Deva, Alvaro Taus, Ana Oaknin, Sylvie Rottey, Irfan Cicin, Sema Sezgin Goksu, Alexey Smolin, Susana Rosello-Keranen, Christin Habigt, Daniel Marbach, Christophe Boetsch, David Dejardin, Nassim Sleiman, Stefan Evers, Muriel Richard, Caroline Ardeshir, Jehad Charo, Anton Kraxner, Volker Teichgraber, Nino Keshelava, Rafal Dziadziuszkoz

A phase 1a/1b study of fostroxacitabine Bralpamide (Fostrox) monotherapy in hepatocellular carcinoma and solid tumor liver metastases

Source
Journal of Hepatocellular Carcinoma - ISSN 2253-5969-11 (2024) p. 2033-2047
Author(s)
    Ruth Plummer, Alastair Greystoke, Gregory Naylor, Debashis Sarker, A.N.M. Kaiser Anam, Hans Prenen, Laure-Anne Teuwen, Eric Van Cutsem, Jeroen Dekervel, Beate Haugk, Thomas Ness, Sujata Bhoi, Malene Jensen, Tom Morris, Pia Baumann, Niclas Sjogren, Karin Tunblad, Hans Wallberg, Fredrik Oberg, Thomas R. Jeffry Evans

Intersectionality between country, gender and funding in authorship for phase III trials presented at the ASCO Annual Meeting 2022

Source
JCO global oncology - ISSN 2687-8941-10 (2024) p. 1-9
Author(s)
    Laure-Anne Teuwen, Joanna Young, Saleh Alessy, Berna C. Ozdemir, Diah Martina, Sharif Folorunso, Maria T. Bourlon, Hans Prenen, Eva Segelov